Why MedTech’s Most Critical Leadership Gap Is Getting Harder to Ignore
Every engineering team under schedule pressure makes tradeoffs. Document it later. Close the risk gap after the milestone. Patch the test protocol after verification. These decisions accumulate quietly—until a 510(k) rejection, an FDA inspection, or a post-market complaint forces a reckoning that costs orders of magnitude more than the original shortcut.

